Strong evidence suggests that food allergies are caused by a lack of exposure to food allergens—not by exposure to toxins ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Redemplo’s approval in familial chylomicronemia syndrome places the drug in competition with Ionis’ Tryngolza.
J&J (JNJ) stock and Halozyme Therapeutics (HALO) stock are in focus as their multiple myeloma therapy Darzalex Faspro is granted traditional FDA nod. Read more here.
ARWR READ THE FULL ARWR RESEARCH REPORT Business Update REDEMPLO® Approved by FDA On November 18, 2025, Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) announced that the U.S. Food and Drug ...